FR3061177B1 - Nouveaux derives piperidinyles hetero(aryle)-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Nouveaux derives piperidinyles hetero(aryle)-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant Download PDF

Info

Publication number
FR3061177B1
FR3061177B1 FR1663463A FR1663463A FR3061177B1 FR 3061177 B1 FR3061177 B1 FR 3061177B1 FR 1663463 A FR1663463 A FR 1663463A FR 1663463 A FR1663463 A FR 1663463A FR 3061177 B1 FR3061177 B1 FR 3061177B1
Authority
FR
France
Prior art keywords
group
methyl
formula
branched
linear
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1663463A
Other languages
English (en)
French (fr)
Other versions
FR3061177A1 (fr
Inventor
Andras Kotschy
Csaba Weber
Attila VASAS
Balazs MOLNAR
Arpad Kiss
Alba Macias
James Brooke MURRAY
Elodie LEWKOWICZ
Lisa IVANSCHITZ
Olivier Geneste
Maia CHANRION
Didier DEMARLES
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Vernalis R&D Ltd
Original Assignee
Laboratoires Servier SAS
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Servier SAS, Vernalis R&D Ltd filed Critical Laboratoires Servier SAS
Priority to FR1663463A priority Critical patent/FR3061177B1/fr
Priority to PL17728567T priority patent/PL3468971T3/pl
Priority to MX2018015212A priority patent/MX2018015212A/es
Priority to PT177285673T priority patent/PT3468971T/pt
Priority to ES17728567T priority patent/ES2778700T3/es
Priority to KR1020197000798A priority patent/KR102003532B1/ko
Priority to CR20180563A priority patent/CR20180563A/es
Priority to PCT/EP2017/064062 priority patent/WO2017212010A1/en
Priority to CU2018000146A priority patent/CU20180146A7/es
Priority to PE2018003132A priority patent/PE20220948A1/es
Priority to AU2017277732A priority patent/AU2017277732B2/en
Priority to US16/306,941 priority patent/US10654849B2/en
Priority to RS20200510A priority patent/RS60279B1/sr
Priority to RU2018147424A priority patent/RU2742271C2/ru
Priority to MDE20190461T priority patent/MD3468971T2/ro
Priority to CN201780047088.4A priority patent/CN109563094B/zh
Priority to HUE17728567A priority patent/HUE048590T2/hu
Priority to SI201730267T priority patent/SI3468971T1/sl
Priority to TNP/2018/000395A priority patent/TN2018000395A1/en
Priority to UAA201900070A priority patent/UA123793C2/uk
Priority to MA45223A priority patent/MA45223B1/fr
Priority to BR112018075284-3A priority patent/BR112018075284A2/pt
Priority to SG11201810576QA priority patent/SG11201810576QA/en
Priority to CA3027008A priority patent/CA3027008C/en
Priority to MYPI2018002417A priority patent/MY196328A/en
Priority to EA201892831A priority patent/EA037563B1/ru
Priority to UY0001037289A priority patent/UY37289A/es
Priority to EP17728567.3A priority patent/EP3468971B1/en
Priority to DK17728567.3T priority patent/DK3468971T3/da
Priority to GEAP201714982A priority patent/GEP20207161B/en
Priority to LTEP17728567.3T priority patent/LT3468971T/lt
Priority to TW106119243A priority patent/TWI647228B/zh
Priority to JP2018564752A priority patent/JP6985299B2/ja
Publication of FR3061177A1 publication Critical patent/FR3061177A1/fr
Priority to PH12018502516A priority patent/PH12018502516B1/en
Priority to SV2018005792A priority patent/SV2018005792A/es
Priority to DO2018000264A priority patent/DOP2018000264A/es
Priority to IL263455A priority patent/IL263455B/en
Priority to ECSENADI201890046A priority patent/ECSP18090046A/es
Priority to CL2018003473A priority patent/CL2018003473A1/es
Priority to CONC2018/0013141A priority patent/CO2018013141A2/es
Priority to ZA2018/08286A priority patent/ZA201808286B/en
Priority to NI201800133A priority patent/NI201800133A/es
Application granted granted Critical
Publication of FR3061177B1 publication Critical patent/FR3061177B1/fr
Priority to HRP20200556TT priority patent/HRP20200556T1/hr
Priority to CY20201100451T priority patent/CY1123069T1/el
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR1663463A 2016-06-10 2016-12-28 Nouveaux derives piperidinyles hetero(aryle)-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant Expired - Fee Related FR3061177B1 (fr)

Priority Applications (44)

Application Number Priority Date Filing Date Title
FR1663463A FR3061177B1 (fr) 2016-12-28 2016-12-28 Nouveaux derives piperidinyles hetero(aryle)-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
PL17728567T PL3468971T3 (pl) 2016-06-10 2017-06-09 Nowe pochodne (hetero)arylo-piperydynylowe, sposoby ich wytwarzania oraz zawierające je kompozycje
MX2018015212A MX2018015212A (es) 2016-06-10 2017-06-09 Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparacion y composiciones farmaceuticas que los contienen.
PT177285673T PT3468971T (pt) 2016-06-10 2017-06-09 Novos derivados de piperidinilo substituídos em (hetero)arilo, um processo para a sua preparação e composições farmacêuticas que os contêm
ES17728567T ES2778700T3 (es) 2016-06-10 2017-06-09 Nuevos derivados de piperidinilo sustituidos con (hetero)arilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
KR1020197000798A KR102003532B1 (ko) 2016-06-10 2017-06-09 새로운 (헤테로)아릴-치환된-피페리디닐 유도체, 이의 제조를 위한 방법 및 이를 함유하는 약학적 조성물
CR20180563A CR20180563A (es) 2016-06-10 2017-06-09 Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que lo contienen
PCT/EP2017/064062 WO2017212010A1 (en) 2016-06-10 2017-06-09 New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
CU2018000146A CU20180146A7 (es) 2016-06-10 2017-06-09 Compuestos derivados de (piperidin-1-ilo)(piperidin-4-ilo) sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen
PE2018003132A PE20220948A1 (es) 2016-06-10 2017-06-09 Nuevos derivados piperidinilo sustituidos con (hetero) arilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen
AU2017277732A AU2017277732B2 (en) 2016-06-10 2017-06-09 New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
US16/306,941 US10654849B2 (en) 2016-06-10 2017-06-09 (Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
RS20200510A RS60279B1 (sr) 2016-06-10 2017-06-09 Novi derivati piperidinila supstituisanog (hetero)arilom, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
RU2018147424A RU2742271C2 (ru) 2016-06-10 2017-06-09 Новые (гетеро)арил-замещенные пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
MDE20190461T MD3468971T2 (ro) 2016-06-10 2017-06-09 Noi derivați de piperidinil (hetero)aril-substituiţi, procedeu de obţinere a acestora și compoziții farmaceutice care îi conțin
CN201780047088.4A CN109563094B (zh) 2016-06-10 2017-06-09 新的(杂)芳基取代的哌啶基衍生物、它们的制备方法和含有它们的药物组合物
HUE17728567A HUE048590T2 (hu) 2016-06-10 2017-06-09 Új (hetero)aril-szubsztituált piperidinil-származékok, eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
SI201730267T SI3468971T1 (sl) 2016-06-10 2017-06-09 Novi derivati piperidinila, substituiranega s (hetero)arilom, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
TNP/2018/000395A TN2018000395A1 (en) 2016-06-10 2017-06-09 New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
UAA201900070A UA123793C2 (uk) 2016-06-10 2017-06-09 Нові (гетеро)арил-заміщені похідні піперидинілу, спосіб їхнього одержання та фармацевтичні композиції, що їх містять
MA45223A MA45223B1 (fr) 2016-06-10 2017-06-09 Nouveaux dérivés de pipéridinyle subsitués par (hétéro)aryle, leur procédé de préparation et compositions pharmaceutiques les contenant
BR112018075284-3A BR112018075284A2 (pt) 2016-06-10 2017-06-09 derivados de piperidinila substituída por (hetero)arila, processo para sua preparação e composições farmacêuticas contendo-os
SG11201810576QA SG11201810576QA (en) 2016-06-10 2017-06-09 New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
CA3027008A CA3027008C (en) 2016-06-10 2017-06-09 (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
MYPI2018002417A MY196328A (en) 2016-06-10 2017-06-09 New (Hetero)Aryl-Substituted-Piperidinyl Derivatives, A Process For Their Preparation And Pharmaceutical Compositions Containing Them
EA201892831A EA037563B1 (ru) 2016-12-28 2017-06-09 Новые (гетеро)арил-замещенные пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
UY0001037289A UY37289A (es) 2016-06-10 2017-06-09 Nuevos derivados piperidinilo sustituidos con (hetero) arilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
EP17728567.3A EP3468971B1 (en) 2016-06-10 2017-06-09 New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
DK17728567.3T DK3468971T3 (da) 2016-06-10 2017-06-09 Nye (hetero)aryl-substituterede piperidinyl-derivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
GEAP201714982A GEP20207161B (en) 2016-06-10 2017-06-09 New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
LTEP17728567.3T LT3468971T (lt) 2016-06-10 2017-06-09 Nauji (hetero)aril-pakeistieji-piperidinilo dariniai, jų gamybos būdas ir juos turinčios farmacinės kompozicijos
TW106119243A TWI647228B (zh) 2016-06-10 2017-06-09 新穎之經(雜)芳基取代之哌啶基衍生物、其製備方法及含其之醫藥組合物
JP2018564752A JP6985299B2 (ja) 2016-06-10 2017-06-09 新規(ヘテロ)アリール置換ピペリジニル誘導体、それを調製するためのプロセス、及びそれを含有する医薬組成物
PH12018502516A PH12018502516B1 (en) 2016-06-10 2018-11-28 New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
SV2018005792A SV2018005792A (es) 2016-06-10 2018-11-29 Nuevos derivados piperidinilo sustituidos con hetero (arilo), un proceso para su preparacion y composiciones farmaceuticas que los contienen
DO2018000264A DOP2018000264A (es) 2016-06-10 2018-12-03 Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen
IL263455A IL263455B (en) 2016-06-10 2018-12-03 New (hetero)aryl-converted-piperidinyl compounds, a process for their preparation and pharmaceutical preparations containing them
ECSENADI201890046A ECSP18090046A (es) 2016-06-10 2018-12-04 Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen
CL2018003473A CL2018003473A1 (es) 2016-06-10 2018-12-04 Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen.
CONC2018/0013141A CO2018013141A2 (es) 2016-06-10 2018-12-04 Nuevos derivados piperidinilo sustituidos con hetero(arilo), un proceso para su preparación y composiciones farmacéuticas que los contienen
ZA2018/08286A ZA201808286B (en) 2016-06-10 2018-12-07 New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
NI201800133A NI201800133A (es) 2016-06-10 2018-12-07 Nuevos derivados piperidinilo sustituidos con (hetero) arilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
HRP20200556TT HRP20200556T1 (hr) 2016-06-10 2020-04-03 Novi (hetero) aril-supstituirani-piperidinil derivati, postupak za njihovu pripravu i farmaceutski pripravci koji ih sadrže
CY20201100451T CY1123069T1 (el) 2016-06-10 2020-05-18 Νεα (ετερο)αρυλ-υποκατεστημενα-πιπεριδινυλ παραγωγα, μεθοδος για παρασκευη αυτων και φαρμακευτικες συνθεσεις που περιεχουν αυτα

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1663463 2016-12-28
FR1663463A FR3061177B1 (fr) 2016-12-28 2016-12-28 Nouveaux derives piperidinyles hetero(aryle)-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
FR3061177A1 FR3061177A1 (fr) 2018-06-29
FR3061177B1 true FR3061177B1 (fr) 2019-09-27

Family

ID=58547622

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1663463A Expired - Fee Related FR3061177B1 (fr) 2016-06-10 2016-12-28 Nouveaux derives piperidinyles hetero(aryle)-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (2)

Country Link
EA (1) EA037563B1 (ru)
FR (1) FR3061177B1 (ru)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR065494A1 (es) * 2007-03-02 2009-06-10 Schering Corp Derivados de piperidina y metodos de uso de los mismos
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
MA41291A (fr) * 2014-12-30 2017-11-07 Forma Therapeutics Inc Dérivés de la pyrrolotriazinone et de l'imidazotriazinone en tant qu'inhibiteurs de la protéase spécifique de l'ubiquitine n° 7 (usp7) pour le traitement d'un cancer
WO2016126926A1 (en) * 2015-02-05 2016-08-11 Forma Therapeutics, Inc. Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors
EP3253759A1 (en) * 2015-02-05 2017-12-13 Forma Therapeutics, Inc. Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors
JP2018504431A (ja) * 2015-02-05 2018-02-15 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的プロテアーゼ7阻害物質としてのチエノピリミジノン

Also Published As

Publication number Publication date
EA037563B1 (ru) 2021-04-14
EA201892831A1 (ru) 2019-06-28
FR3061177A1 (fr) 2018-06-29

Similar Documents

Publication Publication Date Title
RU2743163C2 (ru) Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
EP3178820B1 (en) Pde9- inhibitors with imidazo triazinone backbone
EP2807159B1 (fr) Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent pour le traitement du cancer
EP2829539B1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2906562B1 (en) Pde9i with imidazo pyrazinone backbone
US9956220B2 (en) Imidazo-pyridazine derivatives as casein kinase 1 δ/ϵ inhibitors
US10144737B2 (en) Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitors
KR20160144378A (ko) 브루톤 티로신 키나제 억제제로서 작용하는 폴리플루오로화 화합물
FR3037957A1 (ru)
JP2009513571A (ja) ヤヌスキナーゼ阻害剤として有用なデアザプリン
US20230242533A9 (en) Substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and the use thereof
US9475817B2 (en) Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors
US11174248B2 (en) Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
CN109963852B (zh) 氧代异喹啉衍生物
CN111936144B (zh) Jak抑制剂
CN112292374B (zh) 一种新型磷酸肌醇3-激酶抑制剂及其制备方法和用途
TW202033526A (zh) 用作酪胺酸激酶抑制劑的化合物、包含其的藥物組合物及其用途
WO2016045598A1 (zh) 4-取代吡咯并[2,3-d]嘧啶化合物及其用途
CA2708783A1 (en) Triazolotriazines and triazolopyrazines and the use thereof
US9550796B2 (en) Pyrrolopyrrolone derivatives and their use as BET inhibitors
JP2022543690A (ja) 架橋ヘテロシクリル置換ピリミジン化合物、その調製方法、及びその薬学的使用
FR3061177B1 (fr) Nouveaux derives piperidinyles hetero(aryle)-substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
EP3189060B1 (fr) Derives de n-aryl-2-amino-4-aryl-pyrimidines polyethers macrocycliques comme inhibiteurs de la ftl3 and jak
CN118684665A (zh) 吡啶并吡咯衍生物及其在药物中的用途

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180629

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20220808